NL-OMON44196已完成不适用
A randomized, 2-part, placebo controlled phase 1 study to evaluate safety, tolerability, pharmacokinetics and immunogenicity following single ascending doses (Part 1) and multiple ascending doses (Part 2) of GBR 830 in adult healthy subjects - GBR 830 SAD and MAD study
Glenmark Pharmaceuticals SA0 个研究点目标入组 32 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •- healthy volunteers
- •- 18 - 65 years, inclusive
- •- BMI: 18.5 - 32.0 kg/m2, inclusive
排除标准
- •Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 3 months before the start of this study. Subjects with a history of donating 1 unit of blood (450 mL) blood in the 3 months prior to IP administration or who intend to donate within 3 months of their last scheduled study visit.
研究者
相似试验
尚未招募
1 期
Single ascending dose and multiple ascending dose study of M132101 in healthy subjects.infantile hemangiomaJPRN-jRCT2071230113ishiura Tomoyuki48
招募中
不适用
A phase 1, randomized, placebo-controlled, double-blind, single center, multiple-dose, parallel trial evaluating the impact of apraglutide on gastric emptying of liquids in healthy subjectsShort Bowel SyndromeNL-OMON53626VectivBio AG36
未知
1 期
A phase 1, randomized, placebo-controlled, double-blind, multiple oral dose study of DS-8500a in Japanese healthy male subjectsJPRN-jRCT2080223495DAIICHI SANKYO CO., LTD.36
已完成
1 期
A single and multiple dose study of M127101 in healthy subjectsasal polyp accompanies eosinophilic chronic rhinosinusitisJPRN-jRCT2071230019Tomoyuki Nishiura16
招募中
1 期
A Phase 1 Randomized, Double-blinded, Placebo-controlled, Dose-escalation Clinical Trial to Evaluate the Safety and Immunogenicity of rVSV?G-LASV-GPC Vaccine in Adults in Good General HealthLassa feverPACTR202106625781067IAVI110